Diamond Biofund Inc. (6901.TW)
6901.TW Stock Price Chart
Explore Diamond Biofund Inc. interactive price chart. Choose custom timeframes to analyze 6901.TW price movements and trends.
6901.TW Company Profile
Discover essential business fundamentals and corporate details for Diamond Biofund Inc. (6901.TW) to support your stock research and investment decisions.
Sector
Financial Services
Industry
Asset Management
IPO Date
11 Sept 2023
Employees
33.00
CEO
Pan-Chih Yang
Description
Diamond Biofund Inc. is a venture capital firm specializing in evergreen funds. The firm seeks investment in start-ups and early ventures. It typically invests in biotechnology and medical investments, including new drug R&D, high-end medical equipment, innovative medical services and channels, and agricultural biotechnology. Diamond Biofund Inc. was founded in 2013 and is based in Taipei, Taiwan.
6901.TW Financial Timeline
Browse a chronological timeline of Diamond Biofund Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 9 May 2025
EPS came in at -$0.67, while revenue for the quarter reached -$9.16M.
Earnings released on 31 Dec 2024
EPS came in at -$0.90 falling short of the estimated $0.44 by -303.78%, while revenue for the quarter reached -$607.67M, missing expectations by -247.14%.
Earnings released on 30 Sept 2024
EPS came in at -$0.95 falling short of the estimated $0.38 by -350.00%, while revenue for the quarter reached $5.00K, missing expectations by -100.00%.
Earnings released on 30 Jun 2024
EPS came in at -$0.16 falling short of the estimated $0.34 by -147.06%, while revenue for the quarter reached -$90.73M, missing expectations by -126.22%.
Earnings released on 31 Mar 2024
EPS came in at -$0.95 falling short of the estimated -$0.64 by -48.39%, while revenue for the quarter reached -$773.70M, missing expectations by +50.23%.
Earnings released on 30 Dec 2023
EPS came in at $0.23 surpassing the estimated -$0.64 by +135.19%, while revenue for the quarter reached $214.41M, beating expectations by -141.63%.
Earnings released on 30 Sept 2023
EPS came in at -$1.71 falling short of the estimated -$1.08 by -58.33%, while revenue for the quarter reached -$1.26B, missing expectations by +41.85%.
Stock split effective on 7 Aug 2023
Shares were split 59:50, changing the number of shares outstanding and the price per share accordingly.
Earnings released on 30 Jun 2023
EPS came in at -$1.92, while revenue for the quarter reached -$1.41B.
Earnings released on 31 Mar 2023
EPS came in at -$0.04, while revenue for the quarter reached $7.28M.
Earnings released on 31 Dec 2022
EPS came in at -$1.39, while revenue for the quarter reached -$1.03B.
Earnings released on 30 Sept 2022
EPS came in at $1.65, while revenue for the quarter reached $1.32B.
Earnings released on 30 Jun 2022
EPS came in at -$3.03, while revenue for the quarter reached -$2.24B.
Earnings released on 31 Mar 2022
EPS came in at $3.69, while revenue for the quarter reached $2.97B.
Earnings released on 31 Dec 2021
EPS came in at $1.76, while revenue for the quarter reached $1.52B.
Earnings released on 30 Sept 2021
EPS came in at $1.76, while revenue for the quarter reached $1.52B.
Earnings released on 30 Jun 2021
EPS came in at -$0.08, while revenue for the quarter reached $14.79M.
Earnings released on 31 Mar 2021
EPS came in at -$0.08, while revenue for the quarter reached $14.79M.
6901.TW Stock Performance
Access detailed 6901.TW performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.